INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 178 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2015. The put-call ratio across all filers is 1.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $9,230,000 | -17.5% | 116,000 | +16.0% | 1.26% | +23.7% |
| Q1 2019 | $11,186,000 | +208.0% | 100,000 | +233.3% | 1.02% | +65.5% |
| Q2 2017 | $3,632,000 | +114.0% | 30,000 | +100.0% | 0.62% | +85.8% |
| Q1 2017 | $1,697,000 | -41.5% | 15,000 | -14.3% | 0.33% | -10.3% |
| Q3 2015 | $2,903,000 | -31.3% | 17,500 | 0.0% | 0.37% | -10.6% |
| Q2 2015 | $4,224,000 | -0.1% | 17,500 | +16.7% | 0.41% | -5.9% |
| Q1 2015 | $4,230,000 | +171.2% | 15,000 | +50.0% | 0.44% | +65.4% |
| Q4 2014 | $1,560,000 | -54.7% | 10,000 | -31.3% | 0.27% | -37.6% |
| Q3 2014 | $3,447,000 | – | 14,565 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 640,688 | $14,787,000 | 2.73% |
| DeepCurrents Investment Group LLC | 416,800 | $9,620,000 | 0.33% |
| DUALITY ADVISERS, LP | 105,668 | $2,439,000 | 0.21% |
| EULAV Asset Management | 335,000 | $7,732,000 | 0.21% |
| Virtus ETF Advisers LLC | 19,375 | $447,000 | 0.19% |
| Hennion & Walsh Asset Management, Inc. | 135,214 | $3,121,000 | 0.19% |
| PDT Partners, LLC | 110,592 | $2,552,000 | 0.18% |
| KETTLE HILL CAPITAL MANAGEMENT, LLC | 70,256 | $1,622,000 | 0.16% |
| ALTRINSIC GLOBAL ADVISORS LLC | 168,800 | $3,896,000 | 0.12% |
| WOODWARD DIVERSIFIED CAPITAL, LLC | 8,939 | $206,000 | 0.12% |